Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
Condition: Glioblastoma Interventions: Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF; Drug: Temozolomide; Biological: Tetanus-Diphtheria Toxoid (Td); Biological: GM-CSF; Biological: 111-Indium-labeling of Cells for in vivo Trafficking Studies Sponsor: Gary Archer Ph.D. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain Tumor | Cytomegalovirus | Glioma | Immunotherapy | Research | Study | Temodar | Tetanus